Revenue of leading European pharmaceutical markets 2019
Germany was the leading pharmaceutical market in Europe with a total revenue of over 42.7 billion euros in 2019. France and Italy followed with revenues of 31.8 billion and 29.7 billion euros respectively. The top five were rounded off by Great Britain and Spain, showing the largest EU-markets, otherwise known at the EU-5 (before the Brexit).
German pharmaceutical market
When the turnover of the German pharmaceutical market is broken down, it is prescription drugs that account for the majority of the turnover. Prescription medication accounted for approximately 29.7 billion euros of revenue, followed by pharmacy drugs at 3.03 billion euros.
German pharmaceutical exports
Over a fifteen-year period the value of pharmaceutical exports from Germany has skyrocketed. Increasing from approximately 18.8 billion euros in 2000 to over 83 billion euros in 2018. The leading destination for these exports is the United States with an export value of over 14 billion euros, followed by the Netherlands with an export value of over eight billion euros
German pharmaceutical market
When the turnover of the German pharmaceutical market is broken down, it is prescription drugs that account for the majority of the turnover. Prescription medication accounted for approximately 29.7 billion euros of revenue, followed by pharmacy drugs at 3.03 billion euros.
German pharmaceutical exports
Over a fifteen-year period the value of pharmaceutical exports from Germany has skyrocketed. Increasing from approximately 18.8 billion euros in 2000 to over 83 billion euros in 2018. The leading destination for these exports is the United States with an export value of over 14 billion euros, followed by the Netherlands with an export value of over eight billion euros
